Events:

• 2020 ASM Microbe meeting

• 2020 Union meeting

News:

• publication of BRIEF-TB trial (PMID: 30865794) and inclusion of 1-month HP regimen (developed in our paucibacillary mouse model of preventive therapy) in WHO Rapid Communication on forthcoming changes to the programmatic management of tuberculosis preventive treatment  https://www.who.int/tb/publications/2020/rapid-communication-on-forthcoming-changes-to-tpt/en/
• publication of Nix-TB trial results (PMID: 32130813) (novel BPaL regimen first discovered in our novel regimen development program in collaboration with the TB Alliance: PMID: 26503656)
• publication of NC-005 trial results (PMID: 31732485) (novel BPaZ and BPaMZ regimens first discovered in our novel regimen development program in collaboration with the TB Alliance: PMID: 28630203)
• publication of INHindsight trial results (PMID: 31945300) (trial concept developed after systematic review of potential for dose optimization of TB drugs performed by RESIST-TB initiative: PMID: 22615332